BIOGRAPHY
Daniel Schlessinger, MD, is a dermatologist and Mohs surgeon in Omaha, Nebraska. He attended Northwestern University’s prestigious Honor’s Program in Medical Education with Honors in Classics, followed by medical school at Northwestern University’s Feinberg School of Medicine. After medical school, he completed a Preliminary-Medicine internship year at Harvard’s Massachusetts General Hospital, followed by dermatology residency at Barnes-Jewish Hospital / Washington University in St. Louis, where he served as Chief Resident. He then returned to Northwestern University to complete a dual-accredited fellowship in Mohs micrographic surgery as well as cosmetic dermatologic surgery. In addition to clinical patient care, Dr. Schlessinger remains active in academic research, product development, and medical writing. After coming up with the idea for a medicated lip balm at age 12, he co-founded FixMySkin Healing Balms with his dad and grandfather and successfully obtained two patents for the 1% hydrocortisone balm formulation. He is considered by many to be a thought leader and national expert on the subject of artificial intelligence in dermatology. He has published dozens of articles and co-authored several book chapters on dermatology, dermatologic surgery, and artificial intelligence. He regularly lectures at local, regional, and national academic conferences and remains active in clinical research regarding dermatologic oncology and surgical reconstruction. He serves on the Editorial Board of the Journal of the American Academy of Dermatology and Practical Dermatology and is a regular peer reviewer for Dermatologic Surgery, the Journal of the American Academy of Dermatology, the Journal of Investigative Dermatology, the British Medical Journal, JAAD Case Reports, and the International Journal of Women’s Dermatology. He sits on the American Academy of Dermatology’s Augmented Intelligence Committee and has previously served on the AAD’s Clinical Guidelines Committee. He is a regular commentary author for the American Academy of Dermatology’s Dialogues in Dermatology podcast series. He is also a creator and editor of the first interactive digital whole-slide Mohs pathology textbook, available via PathPresenter.
SESSIONS
DISCLOSURES
AbbVie – Investigator(Fees); Almirall – Investigator(Fees); Alumis – Investigator(Fees); Apollo Therapeutics Ltd – Investigator(Fees); Appiell Inc. – Consultant(Stock); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Celldex – Investigator(Fees); FixMySkin – Founder(Patent royalties or other compensation for Intellectual Property Rights); Incyte Corporation – Investigator(Fees); Ipsen – Investigator(Fees); K-Health – Stockholder(No Compensation Received); LovelySkin – Employee (w-2 relationship)(Salary); LuminDx – Consultant(No Compensation Received); MoonLake Immunotherapeutics – Investigator(Fees); Nielsen BioSciences – Advisory Board(Stock), Investigator(Fees); Novartis – Investigator(Fees); Oruka Therapeutics – Investigator(Fees); Pfizer Inc. – Investigator(Fees); ProTransit Nanotherapy – Advisory Board(Stock), Investigator(Fees); Sanofi – Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Fees); Takeda Pharmaceuticals USA Inc – Investigator(Fees); UCB – Investigator(Fees); VeraDermics Inc. – Advisory Board(Honoraria); Verrica Pharmaceuticals Inc. – Investigator(Fees);